| Previous Close | 146.00 |
| Open | 146.06 |
| Bid | 145.80 x 100 |
| Ask | 145.88 x 200 |
| Day's Range | 145.41 - 146.77 |
| 52 Week Range | 114.53 - 194.66 |
| Volume | 954,546 |
| Avg. Volume | 1,645,334 |
| Market Cap | 30.67B |
| Beta | 1.26 |
| PE Ratio (TTM) | 6.42 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.36 (0.93%) |
| Ex-Dividend Date | 2017-08-30 |
| 1y Target Est | N/A |
- Barrons.com•3 hours ago
Drug Distributors: Bear Vs. Bull Debate
Drug distributors are down about 9% in the past two weeks as investors fret about generic deflation concerns. Morgan Stanley’s Ricky Goldwasser and his team write that without near term catalysts, the stocks are probably going to remain range bound in the near future. Goldwasser writes that competition could escalate, as the Food and Drug Administration approve pending applications from additional manufacturers.
- Zacks•5 days ago
McKesson Banks on Distribution Business Amid Pricing Woes
McKesson (MCK) entered fiscal 2018 with an assumption of branded inflation in the mid-single digits. Pricing pressure in the independent retail pharmacy channel is a headwind.
- TheStreet.com•6 days ago
Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal
Cantor Fitzgerald says Allscripts acquisition of McKesson's Enterprise Information Solutions will provide it material cost saving opportunities.
